Nov
12
2019
On demand

Meeting the scalability challenge of downstream viral vector purification

In the expanding field of gene and cell therapy, continuous flow ultracentrifugation is slowly revealing its ability to overcome downstream bottlenecks. Unlike the more well-known tube rotor designs, continuous flow zonal UCF offers a unique ability to dynamically use revolving zones at high speeds to provide a scalable and cost-effective process for the purification and concentration of viral vectors.

  • Understand the capabilities and benefits of continuous flow ultracentrifugation to purify and concentrate viral vectors (including AAV) in a predictable manner.
  • Assess the scalability and cost-effectiveness of solutions to downstream bottlenecks and gene therapy process development.
  • Discover what makes linear scalability possible with continuous flow ultracentrifugation.
  • Learn how to improve your product recovery and process time.

Seth Brittle
Process Engineer at Alfa Wassermann Separation Technologies
Sandra Merino
Global Project Director at Alfa Wassermann Separation Technologies
Xiaotong Fu
Senior Engineer, Downstream Bioprocess Development, Gene Therapies
George Todorov
Associate Director, Early Stage Process Development at Adverum Biotechnologies, Inc.

SPEAKERS

Seth Brittle
Process Engineer at Alfa Wassermann Separation Technologies
Sandra Merino
Global Project Director at Alfa Wassermann Separation Technologies
Xiaotong Fu
Senior Engineer, Downstream Bioprocess Development, Gene Therapies
George Todorov
Associate Director, Early Stage Process Development at Adverum Biotechnologies, Inc.

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
36
Days
8
Hrs
38
Min
Register

Accelerating cell therapy discovery & development with non-viral gene...

D Hermanson
X Patrinostro
David Hermanson
David Hermanson
Senior Manager of R&D Applications, Cell and Gene Therapy at Bio-techne
Xiaobai Patrinostro
Xiaobai Patrinostro
Manager of Genome Engineering Services, Cell and Gene Therapy at Bio-techne
16 Jun 2022
29
Days
16
Hrs
38
Min
Register

Applying an HPLC analytical platform for mRNA process monitoring

N Pavlin
Nejc Pavlin
Nejc Pavlin
Project Manager in Process Analytics Development at BIA Separations
7 Jun 2022
21
Days
8
Hrs
38
Min
Register

Optimizing E. Coli cell growth performance with in-line, real-time OD600...

T Buch
R Shanbaky
Tanja Buch
Tanja Buch
Technical Director at Biifactory Competence Center
Ramsey  Shanbaky
Ramsey Shanbaky
Bioprocess Applications Manger at C Technologies, Inc - a Repligen Company
1 Jun 2022
14
Days
16
Hrs
38
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
14
Days
8
Hrs
38
Min
Register